Sara K Browning, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-7100 |
Emily Parks, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-8000 |
Mr. Robert Alton Browning, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-7100 |
Theresa Ann Soto, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-8000 Fax: 830-201-8008 |
Davis M Parks, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-8900 |
Bret Allen Merritt, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-7100 Fax: 830-201-7336 |
Micheal Dean Ports, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 810 W Highway 71, Marble Falls, TX 78654 Phone: 830-201-8000 |
News Archive
Researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers.
The Helen F. Graham Cancer Center at Christiana Care is the recipient of $2.8 million from the National Cancer Institute, part of the National Institutes of Health, to expand cancer research.
At its annual assembly in Geneva last week, the World Health Organization approved a radical and far-reaching plan to slow the rapid, extensive spread of antibiotic resistance around the world. The plan hopes to curb the rise caused by an unchecked use of antibiotics and lack of new antibiotics on the market.
PIKAMAB, a biopharmaceutical company specializing in stratified medicine, announced today that it has been awarded two grants by the U.S. Government under the QTDP program to advance the development and commercialization of two theragnostic products: ADCC Therasight and Lupus Therasight. PIKAMAB applied for two grants, both of which qualified and received the maximum grant amounts totaling approximately $488,959.
› Verified 1 days ago